Taysha: Taysha shares positive Rett results in bid to move past roadblocks

Taysha Gene Therapies touted positive early-stage data last month for its gene therapy to treat Rett syndrome, which has become the company's main focus after cutting other programs and laying off 35% of its staff. If successful, the candidate for Rett syndrome has the capability to put Taysha in a billion-dollar market.The post Taysha shares positive Rett results in bid to move past roadblocks appeared first on PharmaLive.